Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2023 / Apr / Glaucoma on My Mind
Glaucoma Research & Innovations Business and Entrepreneurship

Glaucoma on My Mind

New research highlights possible risk factors for the development of normal tension glaucoma

By Sarah Healey 4/5/2023 2 min read

Share

Even though normal tension glaucoma (NTG) affects approximately 50 percent of primary open-angle glaucoma patients, the pathophysiology of the disease remains poorly understood. Now, new research – conducted at the Kaunas University of Technology (KTU), Lithuania – provides additional evidence that intracranial pressure (ICP) and translaminar pressure difference (TPD) play a major role in NTG development (1). The study gathered ICP and visual field perimetry data from 80 early-stage NTG patients referred to the Eye Clinic at the Lithuanian University of Health Sciences between January and October 2018.

Typically, ICP measurements require that a small-sized hole is drilled in the patient’s skull, which limits the use of the metric. In this study, the researchers used a two-depth transcranial doppler, technology invented by Arminas Ragauskas, Head of the Health Telematics Science Institute at KTU (2), to measure ICP non-invasively through the eye using ultrasound. Ragauskas notes that the new technology does not compete with invasive methods, but rather takes us towards “an entirely new direction” for measuring ICP. (Interesting sidenote: Ragauskas also says that his team is constantly developing the invention, with patents for new applications and ambitions to see the technology used in long-term space missions!)

With easier access to ICP,  the team were able to explore several significant correlations between ICP, TPD (gained through the simple formula: TPD = IOP – ICP), and visual field changes. In particular, though lower ICP correlated with lower IOP, higher TPD was associated with significant changes to the patient’s visual field. Out of the five visual zones (nasal, temporal, peripheral, central, and paracentral), the most significant visual field losses occurred in the nasal zone.

The researchers concluded that TPD and lower ICP could be possible risk factors for the development of NTG. Although the relationship between ICP and the visual field has long been acknowledged, the study points to a new avenue of NTG research powered by more accessible ICP measurements.

References

  1. A Stoskuviene et al., “The Relationship between Intracranial Pressure and Visual Field Zones in Normal-Tension Glaucoma Patients,” Diagnostics, 13, 174 (2023). PMID: 36672984.  
  2. EurekAlert, “Low brain pressure could be a risk factor for developing glaucoma” (2023). Available at: bit.ly/3ZMmM0I.

About the Author(s)

Sarah Healey

Communicating stories in a way that is accessible to all was one of the focal points of my Creative Writing degree. Although writing magical realism is a fun endeavor (and one I still dabble in), getting to the heart of human stories has always been the driving motivator behind my writing. At Texere, I am able to connect with the people behind scientific breakthroughs and share their stories in a way that is impactful and engaging.

More Articles by Sarah Healey

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: